• LAST PRICE
    1.9200
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.5236%)
  • Bid / Lots
    1.6900/ 1
  • Ask / Lots
    2.0800/ 15
  • Open / Previous Close
    1.9800 / 1.9100
  • Day Range
    Low 1.8800
    High 2.0077
  • 52 Week Range
    Low 1.2900
    High 2.5000
  • Volume
    26,856
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.91
TimeVolumeRFL
09:32 ET32811.92
09:33 ET2001.92
09:42 ET1591.92
09:57 ET3621.92
10:09 ET7401.9258
10:18 ET22001.91
10:33 ET1101.91
10:36 ET3421.9
10:40 ET1001.9
10:44 ET5261.89
10:54 ET1451.91
11:00 ET30021.91
11:05 ET15001.9241
11:30 ET2921.95
11:32 ET3321.95
11:54 ET3001.98
11:56 ET2002.0077
12:14 ET5001.97
12:33 ET5001.9794
12:57 ET2011.97
01:09 ET3001.98
01:20 ET25001.965
01:31 ET2501.95
01:44 ET2021.975
02:36 ET4001.945
02:57 ET2221.93
02:59 ET10591.93
03:03 ET5001.9389
03:08 ET1001.96
03:12 ET2001.95
04:00 ET40071.92
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRFL
Rafael Holdings Inc
47.1M
-1.3x
---
United StatesCOCH
Envoy Medical Inc
44.1M
-1.7x
---
United StatesNXL
Nexalin Technology Inc
49.1M
-6.1x
---
United StatesHRGN
Harvard Apparatus Regenerative Technology Inc
44.6M
-5.2x
---
United StatesRDGL
Vivos Inc
35.5M
-12.2x
---
United StatesBSGM
BioSig Technologies Inc
34.5M
-1.3x
---
As of 2024-11-26

Company Information

Rafael Holdings, Inc. is a holding company with interests in clinical and early-stage pharmaceutical companies. Its segments include Healthcare, Infusion Technology and Real Estate. It holds a majority equity interest in LipoMedix Pharmaceuticals Ltd. (a clinical-stage pharmaceutical company), Barer Institute Inc. (a preclinical cancer metabolism research operation), and a majority interest in Cornerstone Pharmaceuticals, Inc. (a cancer metabolism-based therapeutics company). It holds a majority interest in Rafael Medical Devices, LLC., an orthopedic-focused medical device company, and a majority interest in Day Three Labs, Inc., a company which empowers third-party manufacturers to reimagine their cannabis offerings enabling them to bring to market predictable versions by utilizing Day Three's pharmaceutical-grade technology and innovation like Unlokt. Its investments include Cyclo Therapeutics Inc. (developing Trappsol Cyclo). It holds a portion of a commercial building in Israel.

Contact Information

Headquarters
520 Broad StreetNEWARK, NJ, United States 07120
Phone
212-658-1450
Fax
302-636-5454

Executives

Executive Chairman of the Board
Howard Jonas
President, Chief Executive Officer
William Conkling
Chief Financial Officer
David Polinsky
Chief Medical Officer
John Goldberg
Lead Independent Director
Stephen Greenberg

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$47.1M
Revenue (TTM)
$637.0K
Shares Outstanding
24.7M
Rafael Holdings Inc does not pay a dividend.
Beta
1.08
EPS
$-1.45
Book Value
$3.34
P/E Ratio
-1.3x
Price/Sales (TTM)
74.0
Price/Cash Flow (TTM)
---
Operating Margin
-16,367.35%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.